Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems

被引：11

作者：

Akturk, Halis K. ^{[1
]}

Battelino, Tadej ^{[2
,3
]}

Castaneda, Javier ^{[4
]}

Arrieta, Arcelia ^{[4
]}

van den Heuvel, Tim ^{[4
]}

Cohen, Ohad ^{[4
]}

机构：

[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA

[2] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

[4] Medtron Int Trading Sarl, Route Molliau 31, CH-1131 Tolochenaz, Switzerland

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷

关键词：

Automated insulin delivery; Time in tight range; Insulin therapy; Closed-loop; Insulin pump; MiniMed (TM); Glucose control; INTERNATIONAL CONSENSUS; DIABETIC-RETINOPATHY; METRICS; COMPLICATIONS; ASSOCIATION; INITIATION;

D O I：

10.1089/dia.2023.0432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The concept of maintaining blood glucose levels within the 70-180 mg/dL range, known as time-in-range, has raised questions regarding its representation of true physiological euglycemia. Some have speculated that focusing on the time spent within the 70-140 mg/dL range, introduced as time in tight range (TITR) through the International Consensus statement, could serve as a more precise metric for assessing normoglycemia in individuals with type 1 diabetes. This article delves into the current status of TITR as an emerging marker and explores how advanced hybrid closed-loop systems may offer a promising avenue for achieving this higher level of glycemic control.

引用

页码：102 / 106

页数：5

共 50 条

[1] A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
Peacock, Sofia
Frizelle, Isolda
Hussain, Sufyan
DIABETES THERAPY, 2023, 14 (05) : 839 - 855
[2] A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
Sofia Peacock
Isolda Frizelle
Sufyan Hussain
Diabetes Therapy, 2023, 14 : 839 - 855
[3] The future of open- and closed-loop insulin delivery systems
Farmer, Terry G., Jr.
Edgar, Thomas F.
Peppas, Nicholas A.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (01) : 1 - 13
[4] Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions
Templer, Sophie
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[5] CLOSED-LOOP DELIVERY SYSTEMS FOR INSULIN THERAPY
BRUNETTI, P
BENEDETTI, MM
CALABRESE, G
REBOLDI, GP
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (04): : 216 - 226
[6] Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes
Folk, Sara
Zappe, Janet
Wyne, Kathleen
Dungan, Kathleen M.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
[7] Closed loop systems-automated insulin delivery (AID)-reality and future
Biester, Torben
Gehr, Bernhard
DIABETOLOGIE, 2024,
[8] Closed-loop insulin delivery systems for patients with diabetes
Garg, Satish K.
Shah, Viral
LANCET DIGITAL HEALTH, 2019, 1 (01): : E2 - E3
[9] A HYBRID ALGORITHM FOR OPTIMIZED CLOSED-LOOP INSULIN DELIVERY IN SILICO
Grosman, B.
Roy, A.
Parikh, N.
Voskanyan, G.
Kaufman, F. R.
Mastrototaro, J.
Keenan, B.
DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A79 - A79
[10] Improvements in A1C and Time-in-Range in DIY Closed-Loop (OpenAPS) Users
Lewis, Dana M.
Swain, Richard S.
Donner, Thomas W.
DIABETES, 2018, 67

← 1 2 3 4 5 →